Who owns CONDUIT PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Conduit Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Conduit Pharmaceuticals stock

Who bought or sold CONDUIT PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Polar Securities 950k $7.2k 0% Mar 2026
 View chart
Saba Capital Management 765k $5.8k 0% Mar 2026
 View chart
Toronto-Dominion Bank 755k $6.0k 0% Mar 2026
 View chart
MMCAP International Inc. SPC 700k $3.9k 0% Dec 2025
 View chart
Clear Street Group 534k $4.4k 100% Mar 2026
 View chart
Decagon Asset Management 400k $2.2k 0% Dec 2025
 View chart
D. E. Shaw & Co 375k $2.8k 0% Mar 2026
 View chart
Boothbay Fund Management 250k $1.3M 0% Mar 2026
 View chart
Wolverine Asset Management 244k $2.0k 0% Mar 2026
 View chart
Rivernorth Capital Management 200k $1.7k 0% Mar 2026
 View chart
SkyView Investment Advisors 150k $1.0k 0% Dec 2025
 View chart
Context Capital Management 129k $976.600000 0% Mar 2026
 View chart
Periscope Capital 105k $798.000000 0% Mar 2026
 View chart
Millennium Management 35k $286.350000 0% Mar 2026
 View chart

Who sold out of Conduit Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Susquehanna International Sep 2025 108k $1.2k